SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
June 6, 2014
Date of report (Date of earliest event reported)
____________________________________
BIOLIFE SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 0-18710 | 94-3076866 | ||
|
(State or Other Juris-
diction of Incorporation)
|
(Commission File No.)
|
(IRS Employer
Identification No.)
|
3303 Monte Villa Parkway, Bothell, WA 98021
(Address of principal executive offices, including zip code)
(425) 402-1400
(Registrant’s telephone number, including area code)
____________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
£ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. REGULATION FD DISCLOSURE
On June 6, 2014, the Board of Directors of BioLife Solutions, Inc. (the “Company”) established June 13, 2014 as the record date for the Company’s 2014 annual meeting of stockholders. The annual meeting is scheduled to be held at 9:00 a.m. on August 6, 2014 at 3303 Monte Villa Parkway, Suite 310, Bothell, Washington 98021.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOLIFE SOLUTIONS, INC.
|
|||
|
Date: June 9, 2014
|
By:
|
/s/ Daphne Taylor | |
|
Daphne Taylor
|
|||
|
Chief Financial Officer
|
|||